Healthcare ❯ Pharmaceuticals

Drug Regulation

FDA Quality Control Prescription Practices Product Recalls FDA Actions FDA Policies Contaminated Medications Codeine-based Medications ANMAT Guidelines for Use Insulin Storage Clinical Trials Quality Assurance Health Investigations Prescription Medications Corporate Compliance Abortion Medications Compliance Issues Indian Pharmacopoeia Compounded Medications Medicines Affordability Side Effects Tirzepatida Substance Abuse Medical Oversight Mifepristone Medical Shops Consumer Safety Public Health Compounding Agencies Safety Standards Medicare Self-Medication Risks

Supreme Court Rejects Drugmakers’ Appeals Over Medicare Price Talks

The move preserves rulings that back the Inflation Reduction Act program, letting new rounds of negotiated discounts proceed.

HHS Denies SSRI Ban Talks as Kennedy Unveils Push to Curb Prescribing

FDA Proposes Blocking Bulk Compounding of GLP-1 Drugs by Outsourcing Facilities

FDA Warns 30 Telehealth Firms Over Misleading Ads for Compounded GLP-1 Drugs

GLP‑1 Use Under Scrutiny After Study on Tolerability and Delhi OTC Sales

DOJ Seeks Pause of Louisiana Abortion-Pill Lawsuit as FDA Reopens Mifepristone Review

Fourth Circuit Affirms West Virginia’s Restriction on Abortion Pill Mifepristone